ResMed (RMD) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $221.97 -0.73%
Revenue Growth %: +6.9%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
NEOV, MANU, CTAS, More
Revenue Growth %: +6.9%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.68, $0.01 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $453.9 million versus the consensus estimate of $455.88 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
